In particular, DNA methylation has been associated with hormone receptor status of breast cancer patients22, 23 and our current study suggests that DNA methylation may be involved in the downregulation of the estrogen receptor in TNBC patients, which was also shown in ref. 15. This evidence concerns the gene NR4A1 and breast carcinoma.